Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samisaz Pharmaceutical is a prominent Iranian pharmaceutical manufacturer based in Mashhad, specializing in the production of a wide range of generic medicinal products. Established in 1994, the company operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Their extensive portfolio includes various dosage forms such as tablets, capsules, and oral liquids, with a strong focus on antibiotics, analgesics, and cardiovascular treatments. Samisaz plays a vital role in the regional healthcare sector by providing affordable access to essential medications for the domestic Iranian market and neighboring countries. The company is particularly recognized for its robust production of beta-lactam antibiotics and respiratory medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samisaz Pharmaceutical.